Intelligence · Clinical Development
Pipeline search results
Programs matching “Astra” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 467 pipeline programs matching "Astra" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
D6830C00003
AstraZeneca AB
Asthma in adults who remain uncontrolled despite medium to high dose ICS plus LABA, and who are at risk of exacerbations.
1 trial -
D6972C00006
AstraZeneca AB
Chronic kidney disease (CKD) and hypertension.
1 trial -
D702KC00001
AstraZeneca AB
metastatic non-small cell lung cancer (NSCLC)
1 trial -
D7080C00001
AstraZeneca AB
Non Small Cell Lung Cancer Colorectal Cancer Pancreatic Ductal Adenocarcinoma
1 trial -
D7230C00001
AstraZeneca AB
Multiple Myeloma
1 trial -
D7260C00001
AstraZeneca AB
Participants living with Obesity or Overweight with at least 1 comorbidity
1 trial -
D7261C00001
AstraZeneca AB
Type 2 Diabetes Mellitus
1 trial -
D7405C00001 (SYRUS)
AstraZeneca AB
B-Cell Acute Lymphoblastic Leukaemia
1 trial -
D7407C00001
AstraZeneca AB
Mantle Cell Lymphoma, Large B-Cell Lymphoma, Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma
1 trial -
D7552C00001
AstraZeneca AB
Moderate-to-Severe Uncontrolled Asthma
1 trial -
D7830C00004
AstraZeneca AB
Non-cirrhotic non-alcoholic steatohepatitis with fibrosis
1 trial -
D7860C00006
AstraZeneca AB
Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
D7986C00001
AstraZeneca AB
Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
1 trial -
D798KC00001
AstraZeneca AB
Solid Tumors, SQ, NSQ NSCLC
1 trial -
D798MC00002
AstraZeneca AB
Sub-study 5: Unresectable Pleural Mesothelioma (Volrustomig Monotherapy), Sub-study 4: Esophageal Squamous Cell Carcinoma (Volrustomig in Combination with Chemotherapy).
1 trial -
D8210C00003
AstraZeneca AB
Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA
1 trial -
D8210C00005
AstraZeneca AB
Asthma
1 trial -
D8220C00036
AstraZeneca AB
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
1 trial -
D822GC00001
AstraZeneca AB
Treatment Naïve Mantle Cell Lymphoma
1 trial -
D8410C00001
AstraZeneca AB
Module 1: advanced/relapsed ovarian, breast, pancreatic or prostate cancer where patients loss of function or predicted loss of function mutation in BRCA1, BRCA2, PALB2, RAD51C, or RAD51D, Module 4: advanced,unresectable and HER2+ metastatic solid tumours; NSCLC, HER2 activating mutation, Module 5: advanced,unresectable or metastatic solid tumours in breast, endometrial, ovarian and prostate cancer, Module 3: advanced/relapsed HER2-negative breast, ovarian, prostate, or pancreatic cancer and expressing BRCA1m, BRCA2m, PALB2m, RAD51Cm or RAD51Dm, IDH-mutant recurrent glioma, breast cancer (without BM), Module 2: IDH-mutant glioma
1 trial -
D8460C00004
AstraZeneca AB
Investigating obesity or overweight condition correlated to many co-morbidities
1 trial -
D8530C00002
AstraZeneca AB
Estrogen Receptor Positive HER2 Negative Advanced Breast Cancer
1 trial -
D9077C00001
AstraZeneca AB
Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer
1 trial -
D9090C00008
AstraZeneca AB
Chronic Heart Failure
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.